Systematic Reviews of Treatments for Polycystic Ovarian Syndrome
Follow the links below to find summaries of systematic reviews of treatments for polycystic ovarian syndrome (PCOS).
Reviewed August 2011
12 Resources Found
Results 1 to 12 displayed.
| Title: | Acupuncture for polycystic ovarian syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovarian syndrome (PCOS) is characterised by the clinical signs of infrequent or very light menstruation, failure to conceive, and excessive hair growth. The current standard western medical treatments for women with PCOS are prescription medi... |
| Date: | Mar 2011 |
| Title: | In vitro maturation in subfertile women with polycystic ovarian hyperstimulation syndrome who are undergoing assisted reproduction |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with polycystic ovarian syndrome undergoing conventional assisted reproduction techniques are at an increased risk of ovarian hyperstimulation. Polycystic ovarian syndrome is often associated with the retrieval of immature oocytes, poor fertilisat... |
| Date: | Feb 2011 |
| Title: | The effect of a healthy lifestyle for women with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome (PCOS) is a very common condition affecting 4% to 18% of women. Being overweight worsens all clinical features of PCOS. These clinical features include reproductive manifestations such as reduced frequency of ovulation and irre... |
| Date: | Sep 2010 |
| Title: | Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome affects menstruation, prevents ovulation and causes hirsutism. Women with PCOS are also at risk of developing metabolic syndrome and have an increased rate of insulin resistance compared with women of similar body weight with n... |
| Date: | Aug 2009 |
| Title: | CHM for subfertile women with PCOS |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovarian syndrome (PCOS) is a complex reproductive endocrinology disease, which may affect the ability of women to conceive. Sixty to 70% anovulatory subfertility are induced by PCOS. Chinese herbal medicines (CHM) have been reported to be an ... |
| Date: | Sep 2008 |
| Title: | Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome (PCOS) is characterised by chronic failure or absence of ovulation (anovulation) and excessive production of male hormones (hyperandrogenism) with the clinical manifestations of irregular menstrual cycles, infertility, hirsutis... |
| Date: | Feb 2008 |
| Title: | Long versus short course treatment with Metformin + Clomiphene Citrate for ovulation induction in women with PCOS |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive-aged women. Apart from infertility, women with PCOS often have other endocrine disorders, including insulin resistance, hyperinsulinaemia and hyperandrogenism. Metform... |
| Date: | Sep 2007 |
| Title: | Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Ovarian surgery in women with clomiphene-resistant polycystic ovarian syndrome reduces the risk of multiple pregnancy without decreasing the pregnancy rate. Women with polycystic ovary syndrome (PCOS) have trouble ovulating. Gonadotrophins are hormones ... |
| Date: | Jul 2007 |
| Title: | Insulin-sensitising drugs versus the combined oral contraceptive pill for symptoms and risks of polycystic ovary syndrome. |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with polycystic ovary syndrome suffer from excessive hairiness (hirsutism), irregular periods, and acne. They are also at greater risk of developing diabetes, cardiovascular disease, and endometrial cancer. In women with polycystic ovary syndrome ... |
| Date: | Nov 2006 |
| Title: | Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Women with polycystic ovary syndrome have menstrual disorders caused by the absence of ovulation. About 20% of women will not ovulate on clomiphene citrate, the primary treatment option. These women can be treated with a surgical procedure like laparosc... |
| Date: | Jul 2003 |
| Title: | Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Not enough evidence to show differences in effect of different kinds of gonadotrophins for polycystic ovary syndrome. Woman with polycystic ovary syndrome (PCOS) have menstrual problems caused by an absence of ovulation. Medical treatment is needed to h... |
| Date: | Feb 2001 |
| Title: | Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | The polycystic ovary syndrome (PCOS) is associated with multiple peripheral ovarian cysts and anovulatory menstrual cycles, which can result in subfertility. Oral anti-oestrogens may restore ovulation in approximately 50% of cases. The remainder may ben... |
| Date: | May 2000 |
Results 1 to 12 displayed.
skip to content



